NFSG
TEVA icon

Newbridge Financial Services Group’s Teva Pharmaceuticals TEVA Stock Holding History

Newbridge Financial Services Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.7K Hold
700
– – ﹤0.01% 669
2026
Q1 		$21.1K Hold
700
– – ﹤0.01% 626
2025
Q4 		$21.8K Hold
700
– – ﹤0.01% 618
2025
Q3 		$14.1K Hold
700
– – ﹤0.01% 824
2025
Q2 		$11.7K Hold
700
– – ﹤0.01% 844
2025
Q1 		$10.8K Hold
700
– – ﹤0.01% 667
2024
Q4 		$15.4K Buy
+700
New +$12.7K ﹤0.01% 658
2024
Q3 		– Sell
-900
Closed -$14.6K – 1062
2024
Q2 		$14.6K Hold
900
– – 0.01% 638
2024
Q1 		$12.7K Sell
900
-7,000
-89% -$88.2K 0.01% 708
2023
Q4 		$82.5K Buy
+7,900
New +$73.8K 0.04% 305
2023
Q3 		– Sell
-9,900
Closed -$74.5K – 1397
2023
Q2 		$74.5K Hold
9,900
– – 0.04% 364
2023
Q1 		$87.6K Hold
9,900
– – 0.05% 342
2022
Q4 		$90.3K Buy
9,900
+4,000
+68% +$34.9K 0.05% 320
2022
Q3 		$48K Buy
5,900
+5,000
+556% +$44.2K 0.03% 464
2022
Q2 		$7K Buy
900
+200
+29% +$1.74K ﹤0.01% 953
2022
Q1 		$7K Hold
700
– – ﹤0.01% 1032
2021
Q4 		$6K Sell
700
-2,000
-74% -$18.1K ﹤0.01% 1043
2021
Q3 		$26K Buy
2,700
+900
+50% +$8.43K 0.02% 592
2021
Q2 		$18K Buy
1,800
+1,100
+157% +$11.6K 0.01% 810
2021
Q1 		$8K Sell
700
-236
-25% -$2.71K 0.01% 963
2020
Q4 		$9K Hold
936
– – 0.01% 755
2020
Q3 		$8K Buy
+936
New +$9.9K 0.01% 734

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Newbridge Financial Services Group's TEVA Position: Q2 2026 in Review

Newbridge Financial Services Group held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 700 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #669.

Newbridge Financial Services Group first reported a position in TEVA in Q3 2020 and has held it in 22 quarters since. The position peaked at $90.3K in Q4 2022. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Newbridge Financial Services Group held 700 shares of Teva Pharmaceuticals worth $23.7K as of Q2 2026.
  • Newbridge Financial Services Group left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #669 holding.
  • Newbridge Financial Services Group first reported a position in Teva Pharmaceuticals in Q3 2020 and has held it in 22 quarters since.
  • Newbridge Financial Services Group's Teva Pharmaceuticals position peaked at $90.3K in Q4 2022.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.